Stay updated on Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.

Latest updates to the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page
- ChecktodayChange DetectedThe footer site revision changed from v3.8.0 to v3.8.1, with no change to the clinical trial record content.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record presents details of a Phase 3 trial comparing ganetespib plus docetaxel with docetaxel alone for advanced NSCLC, including its terminated status and reported study outcomes.SummaryDifference100%

- Check21 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH banner announces a website transition, links to updates and FAQs, and says NIH content may use both “Super Intelligence” and “Artificial Intelligence” during the transition.SummaryDifference1%

- Check35 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

Stay in the know with updates to Ganetespib Combo with Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganetespib Combo with Docetaxel in NSCLC Clinical Trial page.